Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia.
about
New molecular markers in resistant B-CLL.Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones.Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups.BCL6: somatic mutations and expression in early-stage chronic lymphocytic leukemia.
P2860
Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Bcl-6 mutation status provides ...... chronic lymphocytic leukemia.
@en
Bcl-6 mutation status provides ...... chronic lymphocytic leukemia.
@nl
type
label
Bcl-6 mutation status provides ...... chronic lymphocytic leukemia.
@en
Bcl-6 mutation status provides ...... chronic lymphocytic leukemia.
@nl
prefLabel
Bcl-6 mutation status provides ...... chronic lymphocytic leukemia.
@en
Bcl-6 mutation status provides ...... chronic lymphocytic leukemia.
@nl
P2093
P2860
P50
P356
P1433
P1476
Bcl-6 mutation status provides ...... l chronic lymphocytic leukemia
@en
P2093
García-Conde J
Sanchez-Izquierdo D
Sarsotti E
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403304
P577
2004-04-01T00:00:00Z